Analyst Ratings for INmune Bio Inc. (INMB)
INMB Rating Summary
INMB Price Target Summary
- Highest: $8.00 (Maxim Group)
- Lowest: $0.60 (Scotiabank)
- Average: $3.53
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$3.53 (+165.7%)
* Over Last 12-Mos
Rating Score: 5.5 / 10
Percentile Rank: 58%
Avg. $ Target:
$3.53 (+165.7%)
* Over Last 12-Mos
Rating Score: 5.5 / 10
Percentile Rank: 58%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/1/2025 | Scotiabank | George Farmer | Downgrade | Sector Underperform (Sector Outperform) |
0.60 (23.00) |
5.33 (1.33) |
-75.05% | Details |
| 7/1/2025 | BTIG | Thomas Shrader | Downgrade | Neutral (Buy) |
N/A (N/A) |
5.33 (1.33) |
-75.05% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
